Financial Statements

MEDNAX, Inc. (MD)

$19.45

+0.17 (+0.88%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -2865102,0942,048-
Net Income 131-796-1,498269320
Stock Dividends --0-86-2221,728
Dividend Paid -----
Retained Earnings -155-2865102,0942,048

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 132177133124-
Annual Depreciation 36-167658173
Capital Expenditure -32-29-32-49-49
Net PPE 136132177133124

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -4,2844,3832,7101,478
New Purchases -28-16-35-62-35
Intangible and Goodwill 4,2844,3832,7101,4781,505

MEDNAX, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes MEDNAX, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.